Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ida Rashida Khan Bukholm"'
Autor:
Katja Vetvik, John Cristopher Noone, Vahid Bemanian, Torill Sauer, Jürgen Geisler, Vessela N. Kristensen, Ida Rashida Khan Bukholm, Jonas Christoffer Lindstrøm, Joel Touma, Cecilia Söderberg-Nauclér
Purpose We have compared the mutational profiles of human breast cancer tumor samples belonging to all major subgroups with special emphasis on triple-negative breast cancer (TNBC). Our major goal was to identify specific mutations that could be pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe78f7d88b523a08013d6c86dc411651
https://hdl.handle.net/10642/7377
https://hdl.handle.net/10642/7377
Autor:
Vessela N. Kristensen, Hiroko K. Solvang, Jo Anders Rønneberg, Silje H. Nordgard, Ida Rashida Khan Bukholm, Bjørn Naume, Jörg Tost, Ivo Gut, Thomas Fleischer, Christian Daviaud, Anne Lise Børresen-Dale, Ivan Potapenko, Daniel Nebdal, Hege Edvardsen
Publikováno v:
Molecular Oncology. 5:61-76
Breast cancer is a heterogeneous disease that can be divided in subtypes based on histology, gene expression profiles as well as differences in genomic aberrations. Distinct global DNA methylation profiles have been reported in normal breast epitheli
Publikováno v:
Breast Cancer Research and Treatment. 80:199-206
The tumour suppressor gene p53 and its protein controls critical cellular functions in cell cycle regulation as well as in apoptosis. Recently, in an in vitro study on breast cancer cell line MCF-7, the apoptotic function of p53 has been shown to be
Publikováno v:
Breast Cancer Research and Treatment. 48:259-264
Germline mutations in the BRCA1 gene predispose to breast and ovarian cancer. An estimated 45% of families with multiple breast cancer cases and more than 80% of breast-ovarian cancer families are linked to BRCA1. Mutation analyses by collaborative l
Autor:
Vahid Bemanian, Ying Chen, Vessela N. Kristensen, Katja Vetvik, Torill Sauer, Joel Touma, Jürgen Geisler, Ida Rashida Khan Bukholm
Publikováno v:
Cancer Research. 76:LB-246
Introduction. Following the development of novel targeted therapies for selected breast cancer (BC) patients (like HER-2 pos. BC), the subgroup of triple-negative breast cancer (TNBC) patients is still characterized by a poor prognosis and a lack of
Autor:
Vessela N. Kristensen, Hiroko K. Solvang, Anne Lise Børresen-Dale, Jo Anders Rønneberg, Florence Busato, Jovana Jovanovic, Jörg Tost, Therese Sørlie, Ida Rashida Khan Bukholm, Johan Botling, Fredrik Wärnberg, Aslaug Aa Muggerud
Publikováno v:
Breast Cancer Research : BCR
Introduction Ductal carcinoma in situ (DCIS) is a non-invasive lesion of the breast that is frequently detected by mammography and subsequently removed by surgery. However, it is estimated that about half of the detected lesions would never have prog
Autor:
Ying Chen, Hilde Presterud Ødegård, Ida Rashida Khan Bukholm, Joel Touma, Bjørn A. Lindstedt, Torill Sauer, Vahid Bemanian, Jürgen Geisler
Publikováno v:
Cancer Research. 75:121-121
Introduction. The epidermal growth factor receptor (EGFR) is one of the major oncogenes in a variety of human cancers including breast cancer (BC). While EGFR overexpression and/or amplification has been shown to occur frequently in human breast canc